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Salix aegyptiaca L. is known as Musk Willow. S. aegyptiaca extracts and essential oils are important 
areas in drug development with some pharmacological activities in the Middle East, especially in Iran. 
For a long time S. aegyptiaca has been used in traditional medicines for the relief of anemia and vertigo, 
as a cardiotonic agent, as well as a fragrance additive in the preparation of local candies. S. aegyptiaca 
has recently been shown to have antioxidant, anxiolytic activity and hypocholestrolemic effect. High 
amounts of phenols and flavonoids such as gallic acid, caffeic acid, myricetin, catechin, quercetin as 
well as salicin, are reported from the leaves of this plant. 1,4-dimethoxybenzene, phenylethyl alcohol, 
carvone, citronellol, methyleugenol, eugenol, n-tetradecane and 4-methoxyacetophenone were 
identified as the major constituents of the essential oil in leaves of S. aegyptiaca. Due to the easy 
collection of the plant, being widespread and also its remarkable biological activities, this plant has 
become both food and medicine in Iran. This review presents comprehensive analyzed information on 
the botanical, chemical and pharmacological aspects of S. aegyptiaca. 
 





Salix aegyptiaca commonly known as Musk Willow is a 
flowering plant and generally cultivated in some 
provinces of Iran for hedge and ornamental purposes 
(Sonboli et al., 2010). It belongs to Salicaceae family in 
the order of Malpighiales that contains about 55 genera 
and more than 1000 species. The species of the genus 
Salix are deciduous trees and shrubs with simple, 
stipulate leaves alternately arranged on woody stems. 
Based on several publications (Fang-Zhen, 1987; Argus, 
2007; Ohashi, 2000), about 526 distinct species are 
recognized for the genus worldwide. Former Soviet Union 
includes 120 species, the New World 103, China 275, 
Europe 65, Pakistan 26 and Iran 31 species and 6 
hybrids (Maassoumi, 2009). Salix species probably 
originates from the Middle East, especially in Egypt and 
somewhere in Turkey, Iran, Iraq, Armenia, Turkmenistan 
and Afghanistan, but has spread as an ornamental plant 
up to Europe, America and Australia. S. aegyptiaca has 
been known as “Bidmeshk” in Iran and distributed in 
many parts of Iran especially in Urmia, North West of Iran 
(Rabbani et al., 2011). S. aegyptiaca is a deciduous 
shrub growing to 4 - 5 m. It  is  a  vigorous,  fast  growing, 
bushy, deciduous small tree with purplish-red, thick 
branches (Figure 1). Leaves are oblong, serrated, deep 
green above, underside hairy, up to 15 cm long (Figure 
2). The inflorescence is catkin; catkins are fragrant and 
grey. Individual flowers are either male or female, but 
only one sex is to be found on one plant, so both male 
and female plants must be grown if seed is required and 
are pollinated by bees. Male catkins are 4 cm long with 
yellow anthers and probably include one of the used 
parts of this plant (Figure 3). Female catkins are 7.5 cm 
long. The plant is not self-fertile (Zargari, 1988).  
The male inflorescences distillate of the plant has long 
been used in Iranian folklore medicine as cardiotonic, 
treatment of anemia and vertigo, as well as a fragrance 
additive. The aqueous extract and essential oil of these 
inflorescences are also being used in confectionary, 
flavorful syrups and especially in the preparation of a 
local candy (Noghl-e Urmia) (Karimi et al., 2011). 
Ethnobotanically, rheumatic pains, affecting mainly the 
elderly, can be relieved by a decoction or infusion of S. 
aegyptiaca bark (Leporatti and Impieri, 2007). The 
decoction of the leaves or barks has  also  been  used  as  










an antihelminthic and vermifuge remedy. The effect of 
Salix leaves, along with clove bud and Nigella, in the 
treatment of common wart has been reported (Rezaei et 
al., 2008). In addition, S. aegyptiaca is used as laxative, 
cardioprotective, nervous, sedative, hypnotic, somnolent, 
aphrodisiac, orexigenic, carminative and gastro-
protection. The decoction of S. aegyptiaca leaves in 
honey still is used as a nervonic functional food. This 
decoction plus sugar has been used among Iranian and 
Turkish people for maladies like depression, neuropathic 
pain and rheumatoid arthritis (Karimi et al., 2011). 
The Salix family is famous due to its endogenous 
salicylate compounds e.g., salicylic acid and acetyl 
salicylic acid (ASA, Aspirin®). This class of compounds 
exerts anti-inflammatory effects. The anti-inflammatory 
and antinociceptive properties of extracts of Salix family 
may be related to its phytochemicals such as salicin, 
myricetin, kaempferol, quercetin, rutin and luteolin (Qin 
and Sun, 2005; Nahrstedt et al., 2007). These com-
pounds have immunomodulatory and anti-inflammatory 
activities by inhibiting pro-inflammatory cytokine 
production and their receptors (Qin and Sun, 2005; 
Nahrstedt et al., 2007). The considerable myricetin, rutin 
and catechin content of musk willow extracts could 
potentially contribute to the anti-inflammatory functions of 
willow extracts (Enayat and Banerjee, 2009). According 
to Unani medicine, S. aegyptiaca has warm humor nature 
and ethnic herbalists prescribed it for cholelithiasis, 
cholecystitis, arthritis and rheumatism. The essential oil 
of S. aegyptiaca is febrifuge and is dubbed among 
Iranian people for its calming effect on heart and possibly 
its antihypertensive effect (Karimi et al., 2011). 
S. aegyptiaca male catkins are rich in volatile 
components such as р-methoxybenzene, eugenol, 
carvone, cedrene oxide, and geraniol (Salehi-Surmaghi, 
2009). A number of chemical constituents such as 
flavonoids and volatile substances have been isolated 
from different parts of the plant (Karimi et al., 2011; 
Enayat and Banerjee, 2009). From current pharma-
ceutical studies, additional pharmaceutical applications of 
S. aegyptiaca have revealed antioxidant, antiinflam-
matory, analgesic, anxiolytic and  antihyperchlosterolemic  










effects among others (Sonboli et al., 2010; Rabbani et al., 
2011; Karimi et al., 2011; Karawya et al., 2010). 
Since the review and systemic analysis of chemistry, 
pharmacology and clinical properties of S. aegyptiaca 
have not been reported. We prompted to provide the 
currently available information on traditional and local 
knowledge, ethno-biological and ethno-medicinal issues, 
identification of pharmacologically important molecules 
and pharmacological studies on this useful plant. The aim 
of the present article is to introduce S. aegyptiaca as a 
medicinal plant by highlighting its traditional applications, 
as well as the recent findings for novel pharmacological 





The commonly known phytochemical compounds from S. 
aegyptiaca are volatile substances, flavonoids and 
phenolics (Sonboli et al., 2010). р-Methoxybenzene 
(60%), eugenol (21%), decanol (4%), cedrene oxide 
(2.5%) and ocimene (2.3%) were identified as the major 
constituents of S. aegyptiaca male catkins essential oil 
collected from Urmia, North West of Iran, while carvone 
(16%), cedrene oxide (16%), geraniol (10%), carvacrol 
(9%), citronellol (4%) and р-methoxybenzene (2.3%) 
were characterized as the major ones of the essential oil 
of S. aegyptiaca male catkins collected from Shiraz, 
South of Iran (Salehi-Surmaghi, 2009).  
The essential oil of S. aegyptiaca leaves contains 1,4-
dimethoxybenzene (61.5%) as the main component 
accompany with methyleugenol (21%), phenylethyl 
alcohol (10.9%), citronellol (8%), carvone (6%), eugenol 
(6%) and 4´-methoxyacetophenone (3%) (Karimi et al., 
2011). 1,4-Dimethoxybenzene also known as “hydro-
quinone dimethyl ether” is the para form of 
dimethoxybenzene, a volatile aromatic ether with a sweet 
floral odor. It occurs naturally in Salix species (Dötterl et 
al., 2005). The presence of high amounts of phenolics 
including gallic acid, caffeic acid, vanillin, р-coumaric 
acid, myricetin, catechin, epigallocatechin gallate and 
flavonoids such as rutin, quercetin and salicin are 




ANTI-INFLAMMATORY AND ANALGESIC 
PROPERTIES 
 
Although a number of steroidal or non-steroidal anti-
inflammatory drugs have been developed, researchers 
are changing their focus to natural products to develop 
new anti-inflammatory agents due to the side-effects of 
chemical drugs (Hyun and Kim, 2009; Shokrzadeh and 
Saeedi Sarvari, 2009). As a result, the search for other 
alternatives seems necessary and beneficial. Many cells 
and mediators are involved in proceeding inflammation. 
For      example,      macrophages      are    representative  










inflammatory cells involved in acute or chronic inflame-
matory responses by over-production of pro-inflammatory 
cytokines [for example, tumor necrosis factor (TNF)-a, 
interleukin (IL)-1b and granulocyte/macrophage colony 
stimulating factor (GMCSF)] and inflammatory mediators 
(Rhee et al., 2009; Lundberg, 2003; Walsh, 2003).  
The Salix family is famous due to its endogenous 
salicylate compounds e.g., salicylic acid and acetyl 
salicylic acid (ASA, Aspirin
®
) (Karimi et al., 2011). This 
class of compounds exert anti-inflammatory effects 
throughout the inhibition of cyclooxygenase-1 (COX-1) 
and cyclooxygenase-2 (COX-2) leading to the inhibition 
of prostaglandin synthesis (Yu et al., 2002; Mahdi et al., 
2006). The anti-inflammatory and antinociceptive 
properties of extracts of Salix species may be related to 
their phytochemicals such as salicin, myricetin, 
kaempferol, quercetin, rutin and luteolin (Qin and Sun, 
2005; Nahrstedt et al., 2007). These compounds have 
anti-inflammatory activities by inhibiting pro-inflammatory 
cytokine production and their receptors (Qin and Sun, 
2005; Nahrstedt et al., 2007). The considerable myricetin, 
rutin and catechin content of S. aegyptiaca extracts could 
potentially contribute to the anti-inflammatory functions of 
other Salix species extracts (Enayat and Banerjee, 2009). 
Salicin, the major phenolic glycoside present in the 
bioactive extracts in Salix species is considered to be the 
pharmacologically active principle due to its structure 
similarity to aspirin. In animal models, the extracts from 
S. aegyptiaca leaves and male flowers have shown anti-
inflammatory effects in carrageenan-induced paw edema 
and hot plate tests (Karawya et al., 2010; Rabbani et al., 
2010). The aqueous extract of S. aegyptiaca male 
flowers at a dose of 0.3, 0.6 and 1.2 mg/kg showed a 
significant analgesic effect compared to control group 
treated with ASA. In addition, it is demonstrated that the 
analgesic effect of 0.6 mg/kg of the extract was higher 





An antioxidant is defined as any substance that when 
present at low concentrations compared to those of an 
oxidizable substrate, significantly delays or prevents 
oxidation of that substrate (Rhee et al., 2009; Halliwell 
and Gutteridge, 1990; Wiseman et al., 1997; Mates et al., 
1999). Antioxidants are of interest to biologists and 





against damages induced by reactive free radicals 
generated in atherosclerosis, ischemic heart disease, 
cancer, Alzheimer's disease, Parkinson's disease and 
even in aging process (Aruoma, 2003; Hemati et al., 
2010). There are many evidences that natural products 
and their derivatives have efficient anti-oxidative 
characteristics, consequently linked to anti-cancer, 
hypolipidemic, anti-aging and anti-inflammatory activities 
(Rhee et al., 2009; Halliwell et al., 1990; Wiseman et al., 
1997; Hogg, 1998; Mates et al., 1999; Aruoma, 2003; 
Cho et al., 2006). 
The anti-oxidative capacities of S. aegyptiaca male 
catkins were evaluated by determining its effect on 1,1-
diphenyl-2-picrylhydrazyl (DPPH) radical scavenging 
(Sonboli et al., 2010). In DPPH radical-scavenging 
activity assay, the IC50 value was 27.7 µg/ml, which was 
comparable to the synthetic antioxidant butylated hydro-
xytoluene (BHT) (IC50 value = 26.5 µg/ml) as standard. 
Furthermore, antioxidant potential of S. aegyptiaca bark 
was determined by IC50 value equal to19 µg/ml (Enayat 
and Banerjee, 2009). The barks and male catkins have 
the highest antioxidant activity. The molecular mecha-
nism of radical scavenging activity of S. aegyptiaca could 
be attributed to the presence of polyphenolic compounds. 
It has already been exhibited that polyphenolic com-
pounds are responsible for radical scavenging activity, 
due to the ease of their hydrogen atom donation to active 
free radicals (Ho et al., 1994). The potent antioxidant 
activity of S. aegyptiaca supports its possible use as a 
natural antioxidant in food industries and other 





Anxiolytic disorders are among the most prevalent 
disorders that are characterized by symptoms such as 
overriding apprehension or mental tension. Most anxiety 
disorders tend to run a long course and thus require long-
term treatment (Berrios, 1999). A wide range of herbal 
anti-anxiety medicines has been used in the past to treat 
different forms of anxiety disorders. Although synthetic 
drugs such as benzodiazepines have the advantage of 
rapid onset of action, they have the potential to interfere 
with patient’s normal activity and are often difficult to stop 
once the therapy has started. These problems and also 
other side effects that exist with synthetic anxiolytic drugs 
have prompted people to seek natural and herbal 
medicines (Rabbani et al., 2011). 
The extract of the flowers of S. aegyptiaca on elevated 
plus-maze (EPM) model of anxiety in mice produced 
anxiolytic effects and reduced locomotor activity. Oral 
and intraperitoneal (i.p.) administration of the extract 
significantly increased the percentage of time spent in the 
open arms of the EPM at 200 and 100 mg/kg, 
respectively. The flowers extract at 100 and 200 mg/kg 
significantly decreased the animal's locomotor  activity  at  




10 and 15 min time intervals. These doses, however, did 
not affect the ketamine-induced sleeping time. The 100 
mg/kg dose of the plant extract when given by i.p. route 
seemed to be the optimal dose in producing the anxiolytic 





Studies in both animals and humans have demonstrated 
that prolonged high cholesterol concentration in the 
circulating blood positively correlates with developing 
atherosclerosis (Pratico, 2001; Kurosawa et al., 2005). 
These changes are associated with the phenomenon that 
excessive load of cholesterol to the liver, above the 
acceptable level of its normal physiological limit, causes 
the liver to be unable in metabolizing the lipids, thus 
resulting in high cholesterol return in the circulating blood 
(Kushi et al., 1996). 
In Iranian ethno-medicine, S. aegyptiaca has been 
prescribed for ailments like cholecystitis and cholelithiasis 
due to its inhibition of bile acid synthesis or antimicrobial 
effects of its active components like phenylethyl alcohol. 
With respect to the lipid profile, the results suggested a 
time-dependent increase in the plasma total cholesterol 
(TC) level. This increase in TC in S. aegyptiaca-treated 
mice could be mainly due to the lack of protective effects 
of the essential oil of S. aegyptiaca and not due to age, 
since the TC was also increased as early as the first 
week of essential oil administration. A significant increase 
in plasma level of HDL was also observed. This increase 
in HDL can solely be responsible for the observed 
increase in TC since the essential oil might be affecting 
the HDL metabolism in the liver (Eder and Gidez, 1982). 
However, the results support that essential oil of S. 
aegyptiaca has no therapeutic and/or prophylactic effects 
against incoming dyslipidemia in rabbits. The essential oil 
of S. aegyptiaca contains several serum lipid-improving 
phytochemical ingredients such as eugenol and 
citronellol (Holmes and DiTullio, 1962; Germán et al., 
1998). However, the other chemical ingredients in 
essential oil of S. aegyptiaca might participate in the 






The objective of this article has been to show the recent 
advances in the exploration of S. aegyptiaca as phyto-
therapy and to illustrate its potential as a therapeutic 
agent. With the current information, it is evident that S. 
aegyptiaca has pharmacological functions including anti-
inflammatory, analgesic and antioxidant activities, among 
others. As the current information shows, it is also 
possible that phenolic glycosides and flavonoids might be 
useful in the development of new  drugs  to  treat  various  




diseases. However, it must be kept in mind that clinicians 
should remain cautious until more definitive studies 
demonstrate the safety, quality and efficacy of S. 
aegyptiaca. For these reasons, extensive pharma-
cological and chemical experiments, together with human 
metabolism will be a focus for future studies. Finally, this 
article emphasizes the potential of S. aegyptiaca to be 
employed in new therapeutic drugs and provide the basis 
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